Crossmark

RP-HPLC method development and validation of Abacavir, Lamivudine and Zidovudine in combined pharmaceutical dosage by analytical QbD

Published Online: 2025-04-21

Authors

Vanparia, Divyesh

Dedania, Ronak R.

Dedania, Zarna R.
License Information

Text and Data Mining valid from 2025-04-21

Version of Record valid from 2025-04-21
More Information

Article History

Received: 4 September 2024

Accepted: 8 April 2025

First Online: 21 April 2025

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current